Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarizes the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency.PMID:34709591 | DOI:10.1007/s40272-021-00478-8 (Source: Paediatric Drugs)
Source: Paediatric Drugs - October 28, 2021 Category: Pediatrics Authors: Yvette N Lamb Source Type: research
Lonapegsomatropin: Pediatric First Approval
This article summarize s the milestones in the development of lonapegsomatropin leading to this first pediatric approval for the treatment of growth hormone deficiency. (Source: Pediatric Drugs)
Source: Pediatric Drugs - October 28, 2021 Category: Pediatrics Source Type: research
